Viemed Healthcare, Inc. (NASDAQ:VMD) Short Interest Update

Viemed Healthcare, Inc. (NASDAQ:VMD) was the recipient of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 291,200 shares, a drop of 19.4% from the October 31st total of 361,200 shares. Currently, 0.9% of the company’s shares are short sold. Based on an average daily volume of 166,700 shares, the short-interest ratio is currently 1.7 days.

Insider Activity at Viemed Healthcare

In other Viemed Healthcare news, Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $9.28, for a total transaction of $336,502.08. Following the sale, the director now directly owns 107,706 shares in the company, valued at $999,511.68. This represents a 25.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Nitin Kaushal sold 5,995 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $8.58, for a total transaction of $51,437.10. Following the completion of the transaction, the director now directly owns 126,843 shares of the company’s stock, valued at $1,088,312.94. This represents a 4.51 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 72,256 shares of company stock worth $674,739. Insiders own 20.00% of the company’s stock.

Institutional Investors Weigh In On Viemed Healthcare

Several institutional investors have recently modified their holdings of the company. National Bank of Canada FI raised its stake in Viemed Healthcare by 91.2% during the 3rd quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock worth $25,000 after acquiring an additional 1,596 shares in the last quarter. Evernest Financial Advisors LLC acquired a new stake in Viemed Healthcare during the 2nd quarter worth approximately $66,000. Perkins Coie Trust Co acquired a new stake in shares of Viemed Healthcare during the third quarter worth $73,000. PDT Partners LLC acquired a new position in shares of Viemed Healthcare during the third quarter worth about $78,000. Finally, Victory Capital Management Inc. increased its position in Viemed Healthcare by 21.1% during the 2nd quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock worth $84,000 after purchasing an additional 2,226 shares during the period. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Price Performance

Shares of NASDAQ VMD opened at $8.67 on Friday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. The company has a market cap of $337.61 million, a price-to-earnings ratio of 32.11 and a beta of 1.43. The stock’s 50-day moving average is $8.61 and its two-hundred day moving average is $7.60. Viemed Healthcare has a 1-year low of $6.21 and a 1-year high of $10.44.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The business had revenue of $58.00 million during the quarter.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.